The Antibacterial Effect of Silver Nanoparticles on Staphylococcus epidermidis Strains with Different Biofilm-Forming

Denis Swolana1, Małgorzata Kępa1, Danuta Idzik1

  • 1Department of Microbiology and Virology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, ul. Jagiellońska 4, 41-200 Sosnowiec, Poland.

Insights

Silver nanoparticles (AgNPs) show significant antibacterial effects against Staphylococcus epidermidis. Larger AgNPs were more effective against biofilm-forming strains, while smaller ones targeted non-biofilm strains.

Area of Science:

  • Microbiology
  • Nanotechnology
  • Infectious Diseases

Background:

  • Staphylococcus species are significant human pathogens due to their prevalence on skin and mucous membranes.
  • There is a global need for novel anti-staphylococcal agents.
  • Nanoparticles are being investigated for their potential antibacterial properties, with silver nanoparticles (AgNPs) showing recognized activity, though their effect on bacterial biofilms requires further study.

Purpose of the Study:

  • To evaluate the impact of silver nanoparticles (AgNPs) on Staphylococcus epidermidis strains with varying biofilm-forming abilities (BFAs).
  • To determine the influence of AgNP particle size and concentration on antimicrobial activity.

Main Methods:

  • Testing AgNPs (10-100 nm particle size, 1-10 µg/mL concentration) against S. epidermidis strains.
  • Assessing antimicrobial activity in relation to bacterial biofilm-forming abilities.
  • Correlating AgNP effectiveness with particle size and bacterial susceptibility.

Main Results:

  • AgNPs exhibited the highest antimicrobial activity against biofilm-forming S. epidermidis strains.
  • The efficacy of AgNPs against biofilm-forming strains increased proportionally with particle size.
  • Non-biofilm-forming strains were more susceptible to smaller AgNPs (10 nm).

Conclusions:

  • Silver nanoparticles demonstrate potent anti-staphylococcal activity, particularly against biofilm formation.
  • Particle size is a critical factor influencing AgNP efficacy, with larger sizes optimal for biofilm inhibition and smaller sizes for planktonic bacteria.
  • AgNPs represent a promising therapeutic strategy against Staphylococcus epidermidis infections.